Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.
TSLA's fundamentals are deteriorating, with double-digit EPS declines, flat revenue growth, and declining gross margins. Read ...
HAL says it booked Rs 30,400 cr (provisional & unaudited) as revenue for financial year ending on 31 March, 2025, as against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback